Autoimmunity and Inflammation Partnering and Investment Summit 2025

Memo

Returning for its second year, the Autoimmunity and Inflammation Partnering and Investment Summit unites over 80 on-scope and in-strategy companies to increase your success rate, efficiency, and collaborative outcomes. Unite to: Capitalize on protected face-to-face networking with a 100% aligned audience and the One-on-One Partnering system, to efficiently generate higher-yielding deal opportunities and nurture multiple key relationships in a less competitive forum Understand assessment criteria, data package expectations, and due diligence of pharma and investors, and hear invaluable feedback into your financing or development programs Evaluate the total landscape of emerging assets to discuss collaboration and licensing options with similar stakeholders seeking creative partnerships to validate technologies or de-risk asset development URLs:Tickets: https://go.evvnt.com/3123529-2?pid=5569 Brochure: https://go.evvnt.com/3123529-3?pid=5569  Date and Time: Mon, 22 Sep 2025 08:00 - Tue, 23 Sep 2025 15:00 Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States Prices:Drug Developer Pricing - 2 Day Pass: USD 2999.00,Academic Pricing - 2 Day Pass: USD 2599.00,Solution Provider Pricing -: USD 5299.00 Speakers: Nikhil Mutyal, Head of Search and Evaluation, Respiratory and Immunology AstraZeneca, Nick Veomett Vice President, Corporate Development Artiva Biotherapeutics, Shanshan Xu Chief Executive Officer Bambusa Therapeutics, Zaneta Odrowaz Chief Business Officer Attovia Therapeutics, Daniel Passeri President and Chief Executive Officer Cue Biopharma, Hussein Al-Mossawi Vice President, Immunology Research Immunocore, Gregory Frost Chief Executive Officer Exuma Bio, Avirup Bose Vice President, Corporate Development InduPro, Jonathan Zombeck Director, Business Development Visterra, Nicola La Monica Senior Director, Strategic Search and Evaluation Johnson and Johnson, Dan Maziasz Chief Business Officer Kyverna Therapeutics, Vikas Goyal Partner, Growth and Investments Longwood Funds, Carolyn Tyler Senior Director McQuade Center for Strategic Research and Development Otsuka, Javad Rasouli Associate Director, Business Development Otsuka, Carter King Executive Vice President, Business Development Protagonist Therapeutics, Stuart Chaffee Chief Executive Officer QuantX Biosciences, Saifur Rahman Director, Search and Evaluation, Immunology Sanofi Partnering Sanofi, Neil Abdollahian Chief Business Officer Santa Ana Bio, Paras Doshi Director, Business Development Seismic Therapeutic, Tayo Sanders Chief Business Officer Singular Immune, Shinichiro Fuse Partner and Managing Director TPG